UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...
According to an article in the June 2022 issue of Psychiatry Research, "Replicated clinical trials have demonstrated rapid and robust antidepressant effects with ketamine in treatment-resistant ...